Physician profile
Michael Salin
NPI 1881668929
$1,776.41
in general payments reported to CMS, 2019-2025
8 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2021: $34.96 · 2022: $553 · 2023: $149 · 2024: $784 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $375 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $375.00 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $963.98 | 2022-2024 | |
| Nobel Biocare USA | $332.81 | 2019-2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $232.79 | 2021-2024 | Bio-Gide, Geistlich Bio-Gide |
| Depuy Synthes Sales INC. | $119.54 | 2025 | Trumatch |
| Biohorizons Implant Systems INC. | $63.93 | 2024 | Biohorizons |
| Pacira Pharmaceuticals Incorporated | $27.86 | 2024 | Exparel |
| Dentsply Sirona INC | $20.93 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Salin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.